Cannara Biotech Inc.LOVE.TO
Consumer Staples · Food, Beverage & Tobacco · TSX · Canada · cannara.ca
Cannara Biotech Inc. is a vertically integrated Canadian cannabis producer that cultivates, processes, and sells cannabis and cannabis-derivative products. The company operates two large indoor facilities in Quebec totaling over 1,650,000 square feet with 100,000 kilograms of annualized production capacity, and sells products under the TRIBAL, nugz, and ORCHID CBD brands across the Canadian market.
Key ratios
Operating cash flow growth
-4.7%TTM
2025
87.3%2024
80.7%
EPS growth
-35.3%TTM
2025
100.0%2024
-10.0%2023
195.8%
FCF / Sales
4.9%TTM
2025
12.7%2024
3.9%2023
-6.9%
Net margin
9.3%TTM
2025
12.2%2024
7.9%2023
12.1%
ROA
6.3%TTM
2025
8.4%2024
3.2%2023
5.5%
ROE
11.7%TTM
2025
13.8%2024
7.7%2023
9.5%
Revenue growth
14.8%TTM
2025
31.1%2024
42.8%2023
59.8%
Recent news
Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank
Cannara Appoints Nicholas Fozard as Chief Financial Officer
Cannara Establishes Automatic Share Purchase Plan
Cannara annonce une offre publique de rachat dans le cours normal des activités
Cannara Completes Acquisition of Medican Organic Inc.
Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec
Cannara Biotech Inc. (LOVE) Opens the Market
Cannara Announces Graduation to the Toronto Stock Exchange
Cannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expansion Strategy
Track LOVE.TO in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer